by GlobeNewsWire | Mar 23, 2016 | Globe Newswire
RAMSEY, N.J., March 23, 2016 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of certain...
by GlobeNewsWire | Feb 24, 2016 | Globe Newswire
RAMSEY, N.J., Feb. 24, 2016 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of certain...
by GlobeNewsWire | Dec 22, 2015 | Globe Newswire
San Francisco, Dec. 22, 2015 (GLOBE NEWSWIRE) — Global Metal Matrix Composites Market is expected to reach USD 433.3 million by 2022. Burgeoning demand for high performance metal components with enhanced durability, shear strength and light weight for...
by GlobeNewsWire | Nov 10, 2015 | Globe Newswire
RAMSEY, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of certain...
by GlobeNewsWire | Sep 30, 2015 | Globe Newswire
RAMSEY, N.J., Sept. 30, 2015 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of certain...